Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy
  • Project pages
    • Telemedicine BW
    • MDR & IVDR

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 20/12/2010 13248_de.jpg

    Curcumin for the treatment of Alzheimer’s disease and cancer: healthy plant substances and their transport into the body

    Turmeric: Indians swear by the use of this yellow spice and believe in its healing power. In India, turmeric (curcumin) is believed to protect against cancer and help reduce the incidence of Alzheimer’s disease. Along with four academic and five industrial partners, Dr. Jan Frank from the University of Hohenheim is investigating how the effect of curcumin can be enhanced. The German Ministry of Education and Research is supporting the consortium…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/curcumin-for-the-treatment-of-alzheimer-s-disease-and-cancer-healthy-plant-substances-and-their-tran
  • Article - 20/12/2010 13269_de.jpg

    Michael Reth – Immunobiological discoveries that meet resistance

    Dr Michael Reth professor at the Max Planck Institute of Immunobiology and the University of Freiburg and some of his colleagues have recently uncovered the mechanism that foreign substances use to activate B cells of the immune system. The researchers were using synthetic biology methods long before this particular branch of science existed in its present form. Their results require a paradigm change and a revision of the reference books.

    https://www.gesundheitsindustrie-bw.de/en/article/news/michael-reth-immunobiological-discoveries-that-meet-resistance
  • Article - 20/12/2010 13196_de.jpg

    Invisible danger with long-term consequences

    According to official figures mycotoxins which are toxic secondary metabolites produced by moulds are found in around of 20 per cent of the European crop harvest. Even the smallest concentrations of mycotoxins can have devastating toxic effects causing cancer or posing a risk to fertility and development. Alexandra Heussner from the University of Konstanz is investigating ochratoxins whose chronic effect represents a huge danger to human health.

    https://www.gesundheitsindustrie-bw.de/en/article/news/invisible-danger-with-long-term-consequences
  • Article - 20/12/2010 13278_de.jpg

    Gicon: Using controllable biogas production to create virtual power stations

    Conventional biogas plants have the disadvantage that the production of energy cannot be controlled in a flexible way. Therefore, Großmann Ingenieur Consult GmbH (GICON) has developed a fast, simple method for controlling biogas production from renewable resources. In addition, the two-stage dry-wet fermentation process with split hydrolysis makes it possible to control the two stages independently. Heribert Krämer, head of the GICON subsidiary…

    https://www.gesundheitsindustrie-bw.de/en/article/news/gicon-using-controllable-biogas-production-to-create-virtual-power-stations
  • Article - 20/12/2010 The photo shows several white containers in a laboratory shelf.

    ForCare – assessing the risks and benefits of environmental chemicals

    Over the last few years the EU has published a number of new guidelines stipulating thresholds for toxicologically relevant substances in food and other products. Some of these thresholds were implemented following a Greenpeace campaign relating to pesticides in food. The Freiburg-based Fachbüro für Toxikologie und nachhaltige Entwicklung Office for Toxicology and Sustainable Development ForCare played a part in the scientific studies behind this…

    https://www.gesundheitsindustrie-bw.de/en/article/news/forcare-assessing-the-risks-and-benefits-of-environmental-chemicals
  • Dossier - 20/12/2010 13209_de.jpg

    Environmental toxins: effect and origin

    Environmental toxins, also referred to as xenobiotics, are chemicals that do not occur in biological substance cycles; they are difficult to degrade and often have a toxic effect. Xenobiotic substances are becoming an increasing problem because we are constantly exposed to them and because they slowly but surely poison us. The World Health Organisation (WHO) sees xenobiotic substances as factors that contribute, along with other factors, to the…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/environmental-toxins-effect-and-origin
  • Press release - 18/12/2010 Proud winners: students and their supervisors after the award ceremony in Boston

    Gold for a construction kit full of viruses

    With a new strategy for the treatment of tumours, the team at the Freiburg Centre for Biological Signalling Studies (BIOSS) excellence cluster once again secured a top place in the international iGEM competition held by the Massachusetts Institute of Technology (MIT) in Cambridge, USA.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/gold-for-a-construction-kit-full-of-viruses
  • Press release - 14/12/2010 10518_de.jpg

    EU-funded research on genetically modified crops

    In order to help inform debate on genetically modified organisms, the European Commission is publishing a compendium entitled "A decade of EU-funded GMO research". The book summarizes the results of 50 research projects addressing primarily the safety of GMOs for the environment and for animal and human health. Launched between 2001 and 2010, these projects received funding of €200 million from the EU and form part of a 25-year long…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/eu-funded-research-on-genetically-modified-crops
  • Article - 13/12/2010 13190_de.jpg

    Christoph Kleineidam – communication without words

    Neuroethologist Dr. Christoph Kleineidam from the University of Konstanz focuses mainly on ants and their highly sensitive sensory system that allows them to communicate with each other by way of pheromones. He believes that these sensory mechanisms can be technologically implemented in the fields of thermosensor and chemosensor technology in the not-too-distant future.

    https://www.gesundheitsindustrie-bw.de/en/article/news/christoph-kleineidam-communication-without-words
  • Article - 12/12/2010 13208_de.jpg

    Pharmacovigilance: safety becomes a principle

    Tübingen-based CenTrial GmbH established in 2000 is a provider and manager of clinical trials. Pharmacovigilance is an important segment of the companys work CenTrial supports its clinical trial clients in all phases of clinical drug development related to drug safety up until the time a drug enters the market and beyond. The services offered range from the analysis of data to the complete design of the safety management process including…

    https://www.gesundheitsindustrie-bw.de/en/article/news/pharmacovigilance-safety-becomes-a-principle
  • Press release - 12/12/2010

    Do adult stem cells contribute to healing and regeneration?

    The Baden-Württemberg Foundation is providing a total of 1.3 million euros in funding to two stem cell research projects from Ulm. The objective of the researchers working on these projects is to find out how adult stem cells can contribute to organ regeneration and wound healing.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/do-adult-stem-cells-contribute-to-healing-and-regeneration
  • Article - 11/12/2010 13236_de.jpg

    Opportunities, benefits and risks are not so different from each other

    Adverse drug reactions that compromise the safety of drugs do not necessarily mean that the development of a pharmaceutically active agent is immediately stopped. The case of a pharmaceutical agent initially developed by Tübingen-based c-a-i-r biosciences GmbH shows how an undesired event can actually lead to new opportunities. The original agent is now being further developed on a different basis from the original plans.

    https://www.gesundheitsindustrie-bw.de/en/article/news/opportunities-benefits-and-risks-are-not-so-different-from-each-other
  • Article - 09/12/2010 13223_de.jpg

    ‘Sniffer dogs’ working for the agrochemical industry

    As a chemistry student in the 1980s, Thomas Class focused on the investigation of environmental toxins such as dioxin and PCB under the supervision of Professor Karlheinz Ballschmiter. Back then, everybody was talking about the “environment”. The public as well as students and professors at the University of Ulm were all fascinated by the subject. Ulm University institutes were renamed to reflect this interest in the environment. While some of…

    https://www.gesundheitsindustrie-bw.de/en/article/news/sniffer-dogs-working-for-the-agrochemical-industry
  • Press release - 06/12/2010 13179_de.jpg

    Better imaging from bench to bedside

    Euro-BioImaging a project which launches its preparatory phase today aims to provide scientists throughout Europe with open access to state-of-the-art imaging technologies at all levels of biological and biomedical research from bench to bedside. The project is part of the European Commissions European Strategy Forum on Research Infrastructures ESFRI roadmap.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/better-imaging-from-bench-to-bedside
  • Article - 06/12/2010 An Asian in a dark suit presenting data.

    Bioplastics – materials that have the potential to be used in medical technology

    At the recent International Symposium on Biopolymers ISBP in Stuttgart scientists discussed the use of biobased plastics for applications in the field of medical technology. The majority of strategies presented at the symposium will only be ready for market in a few years time. However they give an idea as to why bioplastics are likely to be applied to a greater extent in the field of medical technology.

    https://www.gesundheitsindustrie-bw.de/en/article/news/bioplastics-materials-that-have-the-potential-to-be-used-in-medical-technology
  • Press release - 06/12/2010 13148_de.jpg

    The taster in your water line

    Although drinking water is monitored more strictly than almost anything, our water supply network is still not immune to accidents, wear and tear or targeted attacks. A one-minute warning system for toxins and other substances in water hazardous to health could set off alarms in future if there is a danger.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-taster-in-your-water-line
  • Press release - 06/12/2010 12605_de.jpg

    Kihara Foundation

    Kihara Memorial Yokohama Foundation for the Advancement of Life Sciences called Kihara Foundation was established in 1985 in memory of the late Dr. Hiroshi Kihara a world famous geneticist and evolutionary scientist Professor of Kyoto University for the advancement of Life Sciences.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/kihara-foundation
  • Press release - 05/12/2010 11167_de.jpg

    Baden-Württemberg ahead of all other German states in terms of health research

    Health research for the benefit of individuals is of great importance in Baden-Württemberg. Baden-Württemberg researchers are among the best in the field of health research both on a national and international level. This is reflected in the success achieved by universities research institutions and university hospitals in competitions said Minister President Stefan Mappus and Dr. Dietrich Birk Secretary of State in the Ministry of Science…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/baden-wuerttemberg-ahead-of-all-other-german-states-in-terms-of-health-research
  • Guest article - 05/12/2010 Sandra Barudio (centre) talking with two of her Chinese colleagues in the GenePharma library.

    Report from Jiangsu

    Sandra Barudio a chemist from the University of Freiburg is currently doing four months practical training in the company GenePharma based in Suzhou Jiangsu province China. Barudio arrived in China at the beginning of September 2010 funded by a China grant from the Baden-Württemberg Ministry of Science Research and the Arts. She is a doctoral student in her second year at the Institute of Chemistry at Freiburg University and is doing her doctoral…

    https://www.gesundheitsindustrie-bw.de/en/article/news/report-from-jiangsu
  • Article - 03/12/2010 The photo shows Dr. Bernd Dallmann welcoming the audience to the Science meets Business Day in the Freiburg Concert Hall.

    Review: Science meets Business Day 2010 (part I)

    Germinating seeds biosensors in the human body deaf people learning to hear again and new approaches to combat the flu virus the lectures held at the Science meets Business Day which concluded this years BioValley Science Week once again highlighted the innovations brought about through the joint efforts of research and industrial players on the Upper Rhine.

    https://www.gesundheitsindustrie-bw.de/en/article/news/review-science-meets-business-day-2010-part-i
  • Press release - 03/12/2010

    Nanjing Medicinal Group

    Nanjing Medicinal group a state-owned enterprise is among the top six pharmaceutical conglomerates in China. It is composed of 15 pharmaceutical companies and controls 1000 retail drugstores. A hospital and a research institute are also part of the group.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/nanjing-medicinal-group
  • Article - 03/12/2010 13135_de.jpg

    Review: Science meets Business Day 2010 (part II)

    How can plant physiologists and seed developers work together to achieve an understanding of the processes happening in the germinating plant embryo in order to improve the seed quality of sugar beet? How can virologists find new ways to switch off the flu virus and develop a marketable vaccine in cooperation with industrial partners?

    https://www.gesundheitsindustrie-bw.de/en/article/news/review-science-meets-business-day-2010-part-ii
  • Article - 30/11/2010 The photo shows a hand holding several packages of tablets

    Off-label use in children: the problem is known but improvement happens step by slow step

    The majority of drugs prescribed to children and adolescents have not been specifically licensed for their use. The majority of drugs have been tested and formulated for adults. This so-called off-label practice is associated with greater risks than those one would expect in medicinal therapy. We talked to Michael Kölch senior consultant in the Department of Paediatric and Adolescent PsychiatryPsychotherapy at Ulm University Hospital about this…

    https://www.gesundheitsindustrie-bw.de/en/article/news/off-label-use-in-children-the-problem-is-known-but-improvement-happens-step-by-slow-step
  • Article - 29/11/2010 13038_de.jpg

    Innovative 3D bioreactors for higher cell and tissue quality

    Two projects from Baden-Württemberg were among the winners of the 12th Medical Technology Innovation Competition organised by the German BMBF. One project consists of a new bioreactor technology developed at the Institute of Anatomy of the Centre for Regenerative Biology and Medicine (ZRM) in Tübingen, which seeks to improve the supply of cells and tissue with nutrients and oxygen by cultivating them in aerosols.

    https://www.gesundheitsindustrie-bw.de/en/article/news/innovative-3d-bioreactors-for-higher-cell-and-tissue-quality
  • Article - 29/11/2010 Five vertical white and five vertical pink stripes ; the white strips contain many black spots.<br />

    How axons find their way

    A group of researchers led by Prof. Dr. Martin Bastmeyer from the Institute of Zoology at the Karlsruhe Institute of Technology KIT is investigating how a complex network of molecular landmarks guides fully grown retinal axons to the correct point in the visual centre map. The researchers use chickens as model organism to simulate the mechanisms involved in axonal pathfinding and target recognition in cell cultures and computer simulations.

    https://www.gesundheitsindustrie-bw.de/en/article/news/how-axons-find-their-way

Page 70 / 121

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 68
  • 69
  • 70
  • 71
  • 72
  • …
  • 121
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Newsletter abonnieren

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search